Photoacoustic computed tomography of human extremities

We present a method of imaging angiographic structures in human extremities, including hands, arms, legs, and feet, using a newly developed photoacoustic computed tomography (PACT) system. The system features deep penetration (1.8 cm in muscular tissues) with high spatial and temporal resolutions. A volumetric image is acquired within 5 to 15 s while each cross sectional image is acquired within 100  μs. Therefore, we see no blurring from motion in the imaging plane. Longitudinal and latitudinal cross-sectional images of a healthy volunteer clearly show the vascular network of each appendage and highlight the system’s ability to image major and minor vasculatures, without the use of an external contrast or ionizing radiation. We also track heartbeat-induced arterial movement at a two-dimensional frame rate of 10 Hz. This work substantiates the idea that PACT could be used as a noninvasive method for imaging human vasculatures

Multimodal optical measurement for study of lower limb tissue viability in patients with diabetes mellitus

According to the International Diabetes Federation, the challenge of early stage diagnosis and treatment effectiveness monitoring in diabetes is currently one of the highest priorities in modern healthcare. The potential of combined measurements of skin fluorescence and blood perfusion by the laser Doppler flowmetry method in diagnostics of low limb diabetes complications was evaluated. Using Monte Carlo probabilistic modeling, the diagnostic volume and depth of the diagnosis were evaluated. The experimental study involved 76 patients with type 2 diabetes mellitus. These patients were divided into two groups depending on the degree of complications. The control group consisted of 48 healthy volunteers. The local thermal stimulation was selected as a stimulus on the blood microcirculation system. The experimental studies have shown that diabetic patients have elevated values of normalized fluorescence amplitudes, as well as a lower perfusion response to local heating. In the group of people with diabetes with trophic ulcers, these parameters also significantly differ from the control and diabetes only groups. Thus, the intensity of skin fluorescence and level of tissue blood perfusion can act as markers for various degrees of complications from the beginning of diabetes to the formation of trophic ulcers

Focal Spot, Summer 2002

https://digitalcommons.wustl.edu/focal_spot_archives/1091/thumbnail.jp

Study of tissue temperature distribution during laser-immunotherapy for cancer treatment

Scope and Method of Study: The ideal cancer treatment modality should not only cause primary tumor suppression but also induce an anti-tumor immunity, which is essential in controlling metastatic tumors. Motivation of this work is to monitor temperature during laser-cancer treatment. A Monte Carlo method for the light transport in tissue and a finite difference method for the solution of heat diffusion equation were performed to estimate the laser dose parameters, and concentration levels of dye and immunoadjuvant. The specimens used were gelatin phantom, rats and mice. Magnetic Resonance Imaging thermometry (MRT) and infrared thermography (IRT) have been used for the measurement of temperature in the biological tissues during treatment of the primary tumors. Thermal imaging is used to estimate the laser-dose in application to cancer treatment. The thermal imaging and dose calculation can increase the level of safety in the treatment by providing information on target tissue and also on surrounding normal tissue.Findings and Conclusions: Magnetic Resonance Imaging (MRI) has been applied to measure the thermal distribution in gel phantom and tumor-bearing rats during laser treatment. Infrared thermography has been applied to measure the surface temperature under the same conditions in tumor-bearing mice. Intratumoral injection of both indocyanine green (ICG) and glycated chitosan (GC) followed by 805-nm laser irradiation has been found efficacious in the cancer treatment. The temperature rise with ICG and laser combination therapy was about 25 °C and with the ICG, GC, and laser combination therapy, the temperature increased by 30 °C. This infers that ICG and GC injection potentiates the laser-immunotherapy. In both the cases, the tumor temperature attains the cancer cell damage temperature range of 60 °C - 70 °C resulting in an increase in the survival time of the treated mice. More importantly, the temperature profiles in this study agree with the Monte Carlo simulation results. In summary, a combination therapy using a laser, a laser-absorbing dye, and an immunoadjuvant guided by temperature measurement probes, such as MRT and IRT, is an effective treatment modality

Multimodal Ultrasound Imaging for Improved Metastatic Lymph Node Detection

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and is complex in nature due to the variety of organs located in the head and neck region. Knowing the metastatic state of the lymph nodes is paramount in accurately staging and treating HNSCC patients. Currently, metastatic lymph node detection involves the use of magnetic resonance imaging and/or x-ray computed tomography, followed by biopsies for histological confirmation. The main diagnostic criteria is the size of the nodes; however, current imaging methods are not 100% accurate due natural lymph node variability. Ultrasound imaging is able to provide additional biological information in addition to lymph node size such as the hilus state, presence of necrosis and vascular information, but it is hindered by poor resolution and limited contrast. Augmenting ultrasound for metastatic lymph node detection has clinical potential due to the availability of ultrasound in the clinic, reduced radiation exposure and minimized patient morbidity. This thesis focuses on augmenting ultrasound with photoacoustic imaging or with nanoparticle contrast agents for improved detection of lymph node metastasis. First, the development of an ultrasound-photoacoustic (USPA) imaging system is described. The USPA system is capable of imaging blood oxygen saturation (sO2), a promising criteria to differentiate between metastatic and healthy lymph nodes. To correct for tissue-dependent attenuation of light in tissue, a deep neural network was developed and trained using Monte-Carlo simulated and experimentally acquired photoacoustic data for better sO2 predictions. Secondly, to improve ultrasound sensitivity to metastatic cells, molecularly targeted phase change perfluorohexane nanodroplets conjugated to epidermal growth factor receptor (EGFR) antibodies (PFHnD-Abs) were developed. It is shown that the PFHnD-Abs are able to specifically bind to HNSCC cells and improve the ultrasound contrast of the cells, opening the door to targeted metastatic lymph node detection. Lastly, to validate the use of the PFHnD-Abs in-vivo, a paired agent imaging approach was adopted by using using a perfluoropentane core nanodroplet (PFPnD) as a non-targeted imaging agent to enable multiplex ultrasound imaging in vivo. Overall, this work expands the potential of ultrasound for metastatic lymph node detection

The Integration of Positron Emission Tomography With Magnetic Resonance Imaging

A number of laboratories and companies are currently exploring the development of integrated imaging systems for magnetic resonance imaging (MRI) and positron emission tomography (PET). Scanners for both preclinical and human research applications are being pursued. In contrast to the widely distributed and now quite mature PET/computed tomography technology, most PET/MRI designs allow for simultaneous rather than sequential acquisition of PET and MRI data. While this offers the possibility of novel imaging strategies, it also creates considerable challenges for acquiring artifact-free images from both modalities. This paper discusses the motivation for developing combined PET/MRI technology, outlines the obstacles in realizing such an integrated instrument, and presents recent progress in the development of both the instrumentation and of novel imaging agents for combined PET/MRI studies. The performance of the first-generation PET/MRI systems is described. Finally, a range of possible biomedical applications for PET/MRI are outlined

Molecular Biomechanics: The Molecular Basis of How Forces Regulate Cellular Function

Recent advances have led to the emergence of molecular biomechanics as an essential element of modern biology. These efforts focus on theoretical and experimental studies of the mechanics of proteins and nucleic acids, and the understanding of the molecular mechanisms of stress transmission, mechanosensing and mechanotransduction in living cells. In particular, single-molecule biomechanics studies of proteins and DNA, and mechanochemical coupling in biomolecular motors have demonstrated the critical importance of molecular mechanics as a new frontier in bioengineering and life sciences. To stimulate a more systematic study of the basic issues in molecular biomechanics, and attract a broader range of researchers to enter this emerging field, here we discuss its significance and relevance, describe the important issues to be addressed and the most critical questions to be answered, summarize both experimental and theoretical/computational challenges, and identify some short-term and long-term goals for the field. The needs to train young researchers in molecular biomechanics with a broader knowledge base, and to bridge and integrate molecular, subcellular and cellular level studies of biomechanics are articulated.National Institutes of Health (U.S.) (grant UO1HL80711-05 to GB)National Institutes of Health (U.S.) (grant R01GM076689-01)National Institutes of Health (U.S.) (grant R01AR033236-26)National Institutes of Health (U.S.) (grant R01GM087677-01A1)National Institutes of Health (U.S.) (grant R01AI44902)National Institutes of Health (U.S.) (grant R01AI38282)National Science Foundation (U.S.) (grant CMMI-0645054)National Science Foundation (U.S.) (grant CBET-0829205)National Science Foundation (U.S.) (grant CAREER-0955291

Optical Diagnostics in Human Diseases

Optical technologies provide unique opportunities for the diagnosis of various pathological disorders. The range of biophotonics applications in clinical practice is considerably wide given that the optical properties of biological tissues are subject to significant changes during disease progression. Due to the small size of studied objects (from μm to mm) and despite some minimum restrictions (low-intensity light is used), these technologies have great diagnostic potential both as an additional tool and in cases of separate use, for example, to assess conditions affecting microcirculatory bed and tissue viability. This Special Issue presents topical articles by researchers engaged in the development of new methods and devices for optical non-invasive diagnostics in various fields of medicine. Several studies in this Special Issue demonstrate new information relevant to surgical procedures, especially in oncology and gynecology. Two articles are dedicated to the topical problem of breast cancer early detection, including during surgery. One of the articles is devoted to urology, namely to the problem of chronic or recurrent episodic urethral pain. Several works describe the studies in otolaryngology and dentistry. One of the studies is devoted to diagnosing liver diseases. A number of articles contribute to the studying of the alterations caused by diabetes mellitus and cardiovascular diseases. The results of all the presented articles reflect novel innovative research and emerging ideas in optical non-invasive diagnostics aimed at their wider translation into clinical practice

Developing novel fluorescent probe for peroxynitrite: implication for understanding the roles of peroxynitrite and drug discovery in cerebral ischemia reperfusion injury

Session 7 - Oral PresentationsSTUDY GOAL: Peroxynitrite (ONOO‐) is a cytotoxic factor. As its short lifetime, ONOO‐ is hard to be detected in biological systems. This study aims to develop novel probe for detecting ONOO‐ and understand the roles of ONOO‐ in ischemic brains and drug discovery ABSTRACT: MitoPN‐1 was found to be a ONOO‐ specific probe with no toxicity. With MitoPN‐1, we studied the roles of ONOO‐ in hypoxic neuronal cells in vitro and MCAO …postprin